{"data":{"id":"us-la/rs-40-2255.1","jurisdiction":"us-la","citation":"RS 40:2255.1","heading":"Definitions","body":"As used in this Part, the following words have the following meanings unless the context indicates otherwise:\n(1) \"Prescription drug\" means a drug as defined in 21 U.S.C. 321.\n(2) \"Prescription drug marketing\" means to provide educational or marketing information or materials regarding a prescription drug in any form including but not limited to all of the following:\n(a) Face-to-face meetings.\n(b) Physical mailings.\n(c) Telephone conversations.\n(d) Electronic mail or facsimile.","path":["TITLE 40. PUBLIC HEALTH AND SAFETY","PART VIII. PHARMACEUTICAL COST TRANSPARENCY","SUBPART A. GENERAL PROVISIONS"],"source_url":"https://www.legis.la.gov/legis/Law.aspx?d=1054679","current_through":"2025 First Extraordinary Session","vintage":"","retrieved_at":"2026-09-14T05:01:25Z","sha256":"110db3521de47f2004f6745af9fe818144f10086e6563aca7895c8aa51f59d6f","source_id":"us-la","stale":false,"prev":"us-la/rs-40-2254.12","next":"us-la/rs-40-2255.11"},"notice":"GroundRules: Original legal text. Not legal advice."}